Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Inovio Pharma (INO)

Inovio Pharma (INO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 414,152
  • Shares Outstanding, K 249,489
  • Annual Sales, $ 1,770 K
  • Annual Income, $ -303,660 K
  • 60-Month Beta 1.08
  • Price/Sales 34.66
  • Price/Cash Flow N/A
  • Price/Book 1.64
Trade INO with:

Options Overview Details

View History
  • Implied Volatility 269.69% ( +188.05%)
  • Historical Volatility 80.63%
  • IV Percentile 88%
  • IV Rank 43.22%
  • IV High 571.55% on 07/06/22
  • IV Low 39.88% on 10/10/22
  • Put/Call Vol Ratio 0.88
  • Today's Volume 1,463
  • Volume Avg (30-Day) 2,788
  • Put/Call OI Ratio 0.37
  • Today's Open Interest 45,377
  • Open Int (30-Day) 78,950

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.16
  • Number of Estimates 3
  • High Estimate -0.14
  • Low Estimate -0.18
  • Prior Year -0.50
  • Growth Rate Est. (year over year) +68.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3950 +19.00%
on 12/28/22
1.9900 -16.58%
on 01/13/23
+0.2500 (+17.73%)
since 12/27/22
3-Month
1.3900 +19.42%
on 12/27/22
2.6100 -36.40%
on 11/15/22
-0.4000 (-19.42%)
since 10/27/22
52-Week
1.3800 +20.29%
on 06/16/22
4.2800 -61.21%
on 02/01/22
-2.0600 (-55.38%)
since 01/27/22

Most Recent Stories

More News
First Wave (FWBI) IND Filing Under FDA's Review, Stock Up

First Wave's (FWBI) stock gains as FDA reviews its IND amendment for the planned phase II study of an enhanced enteric microgranule delivery formulation of adrulipase.

INO : 1.6600 (unch)
SNDX : 28.33 (+3.51%)
FWBI : 5.71 (+0.53%)
ETON Up as FDA Accepts NDA for Dehydrated Alcohol Injection

Eton (ETON) gains as the its new drug application (NDA) for dehydrated alcohol injection for methanol poisoning is accepted for review by the FDA.

INO : 1.6600 (unch)
SNDX : 28.33 (+3.51%)
ETON : 3.64 (unch)
bluebird (BLUE) Updates on Progress With Zynteglo, 2023 Outlook

bluebird bio, Inc. (BLUE) updates on the launch of gene therapy Zynteglo and provides cash burn guidance for 2023.

INO : 1.6600 (unch)
BLUE : 6.23 (-1.58%)
SNDX : 28.33 (+3.51%)
INOVIO Provides an Update on Lassa Fever and MERS Programs

/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and prevent infectious...

INO : 1.6600 (unch)
3 Stocks to Avoid Right Now

Even though many stocks have fallen sharply in price, not all are bargains -- investors must remains selective.

BIIB : 291.35 (-0.20%)
INO : 1.6600 (unch)
OCGN : 1.2200 (+1.67%)
While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants

EQNX::TICKER_START (OTCQB:BIXT),(NASDAQ:NVAX),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:INO),(NASDAQ:BNTX) EQNX::TICKER_END

NVAX : 10.82 (-1.46%)
PFE : 44.14 (-0.25%)
BNTX : 141.84 (-0.49%)
MRNA : 192.22 (-0.53%)
INO : 1.6600 (unch)
BIXT : 0.4751 (-1.00%)
Inovio Pharmaceuticals (INO) Q3 2022 Earnings Call Transcript

INO earnings call for the period ending September 30, 2022.

INO : 1.6600 (unch)
Inovio Pharmaceuticals (INO) Reports Q3 Loss, Tops Revenue Estimates

Inovio (INO) delivered earnings and revenue surprises of 48.28% and 3,880%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

INO : 1.6600 (unch)
VBIV : 0.5600 (-2.61%)
Inovio: Q3 Earnings Snapshot

Inovio: Q3 Earnings Snapshot

INO : 1.6600 (unch)
INOVIO Reports Financial Results and Highlights for the Third Quarter 2022

/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and prevent infectious...

INO : 1.6600 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled...

See More

Key Turning Points

3rd Resistance Point 1.8787
2nd Resistance Point 1.8269
1st Resistance Point 1.7435
Last Price 1.6600
1st Support Level 1.6083
2nd Support Level 1.5565
3rd Support Level 1.4731

See More

52-Week High 4.2800
Fibonacci 61.8% 3.1722
Fibonacci 50% 2.8300
Fibonacci 38.2% 2.4878
Last Price 1.6600
52-Week Low 1.3800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar